Kenvue to Announce Third Quarter 2024 Financial Results
Kenvue Inc. (NYSE: KVUE), recognized as the largest pure-play consumer health company globally by revenue, is set to announce its comprehensive financial results for the third quarter of 2024. This announcement will take place before the stock market opens, creating anticipation among investors and stakeholders alike.
Details of the Upcoming Announcement
The announcement is scheduled for November 7, 2024. Kenvue’s management team will host a live conference call in conjunction with the results release. This call is an opportunity for investors, analysts, and interested parties to gain insights directly from Kenvue’s leadership team. The conference call is set to begin at 8:00 a.m. Eastern Time. Participants in the U.S. can join by calling 877-407-8835, while those calling internationally can dial +1 201-689-8779.
Accessing the Livestream and Replay
For those unable to join the live discussion, Kenvue will offer a webcast of the conference call. This webcast can be accessed through Kenvue’s investor relations website. A replay will also be available for those who wish to listen at a later time, ensuring that all interested parties can stay informed about the company’s financial performance and business outlook.
About Kenvue Inc.
Founded on a rich legacy of over a century, Kenvue delights consumers with its trusted and iconic brand portfolio. Renowned brands such as Aveeno, BAND-AID, Johnson’s, Listerine, Neutrogena, and Tylenol form the backbone of Kenvue's offering, all backed by science and trusted by healthcare professionals globally.
Kenvue's Commitment to Consumer Care
At Kenvue, the mission focuses on empowering everyday care for consumers. Their team works diligently to maintain the strength of their brands in the hearts and homes of consumers. Through innovation and dedicated service, Kenvue continues to enhance the everyday health experience, showcasing the extraordinary power of fundamental care.
Significance of the Financial Results
As a key player in the consumer health industry, Kenvue's quarterly financial results serve as an essential indicator of its operational performance and market position. Investors and stakeholders eagerly await these results to assess the company's trajectory amidst a competitive landscape. A strong performance not only boosts investor confidence but also reinforces Kenvue's position as a leader in consumer health.
Frequently Asked Questions
When will Kenvue announce its Q3 2024 results?
Kenvue is set to announce its Q3 2024 financial results on November 7, 2024.
How can I access the conference call?
Investors can dial 877-407-8835 from the U.S. or +1 201-689-8779 internationally to join the call.
Where can I find the webcast of the conference call?
The webcast will be available on Kenvue’s investor relations website after the announcement.
What brands are under Kenvue?
Kenvue's portfolio includes well-known brands like Aveeno, Listerine, Neutrogena, and Tylenol.
Why are Kenvue's financial results important?
The results provide insights into Kenvue's performance and strategic direction in the competitive consumer health market.
